BriaCell Therapeutics Insider Trades

BCTX

Track insider trading activity from BriaCell Therapeutics executives and directors. See which insiders are buying and selling BCTX stock.

Trades Last 12 Months

BCTX Price

All Insider Trades for BriaCell Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lustig Marc 10% owner
Holding Value $8.29M 2,542,935 shares
Last Trade
May 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.6M 902,935 shares
$31.65
$3.26
Holding Value $554k 169,856 shares
Last Trade
Dec 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.91M 28,000 shares
$68.18
$3.26
Williams William V. President, CEO
Holding Value $97.2k 29,802 shares
Last Trade
Dec 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$175k 2,530 shares
$69.00
$3.26
Gross Jane A Director
Holding Value $0 0 shares
Last Trade
Aug 01, 2022 Sale
$4.81M 50,000 shares
$96.15
$3.26
Levin Gadi CFO & Secretary
Holding Value $9.16k 2,810 shares
Last Trade
Aug 01, 2022 Sale
$19.2M 20,000 shares
$961.50
$3.26
Lopez Lago Miguel A. Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Aug 01, 2022 Sale
$1.44M 15,000 shares
$96.15
$3.26
Holding Value $0 0 shares
Last Trade
Aug 01, 2022 Sale
$4.81M 50,000 shares
$96.15
$3.26
Holding Value $1.87k 575 shares
Last Trade
Aug 01, 2022 Sale
$48.1M 50,000 shares
$961.50
$3.26
Taub Rebecca Director
Holding Value $0 0 shares
Last Trade
Aug 01, 2022 Sale
$962k 10,000 shares
$96.15
$3.26
Williams Williams V. President & CEO
Holding Value $488k 149,636 shares
Last Trade
Aug 01, 2022 Sale
$21.4M 22,300 shares
$961.50
$3.26
Del Priore Giuseppe Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Aug 01, 2022 Sale
$14.4M 150,000 shares
$96.15
$3.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up